[Q3/2023] PharmaLogic News: Quarter in Review

#ICYMI: In Case You Missed It

• Ratio Therapeutics, In Collaboration with Lantheus and PharmaLogic, Announce First Patient Dosed in Phase I Study Evaluating a Novel FAP-Targeted Radiopharmaceutical for PET Imaging
• PharmaLogic Denver: Cyclotron Delivery Video
• PharmaLogic Takes Delivery of Cyclotron for Atlanta Facility
• PharmaLogic in Vienna for the 2023 EANM Meeting
• All About Therapeutics: PharmaLogic Exhibits at the 2023 SNMMI Therapeutics Meeting

Expanding Patient Access: New Cyclotron Deliveries

Deleted Scenes: Cyclotron Delivery in Denver

Last month, we released a video detailing the delivery of our second GE HealthCare PETtrace 890 cyclotron for our facility in Denver, Colorado. The facility expansion will increase manufacturing capability of key radioisotopes and enhance patient access to novel radiopharmaceuticals in the region.

A Cyclotron for Atlanta

At the end of September, we took delivery of another PETtrace 890 cyclotron from GE HealthCare for our newest facility in Atlanta, Georgia! The new facility will expand patient access to the latest advances in radiopharmaceutical technology within the greater Atlanta area and local communities.

CE Saturdays

This quarter marked the end of our CE Saturday series! After traveling to several cities where we have dedicated customers, we ended our series in Columbia, MO. Check out some photos from Q3's stops on our tour!

Coming Up Next

Don’t miss PharmaLogic at your local SNMMI Chapter fall meetings! Subscribe to our newsletter and follow us on LinkedIn to explore where we'll be next.